Biophotonics Market (By End-use: Tests and Components, Medical Therapeutics, Medical Diagnostics, Non-medical Application; By Technology: In-Vitro, In-Vivo; By Application: See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics sensing, Light therapy, Surface imaging, Biosensors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biophotonics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biophotonics Market, by End-use, 2024-2034
8.1.1 Tests and Components
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Medical Therapeutics
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Medical Diagnostics
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Non-medical Application
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Biophotonics Market, by Technology, 2024-2034
9.1.1. In-Vitro
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. In-Vivo
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Biophotonics Market, by Application, 2024-2034
10.1.1. See-Through imaging
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Microscopy
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Inside Imaging
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Spectro Molecular
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Analytics sensing
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Light therapy
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Surface imaging
10.1.7.1. Market Revenue and Forecast (2021-2034)
10.1.8. Biosensors
10.1.8.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by End-use (2021-2034)
11.1.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by End-use (2021-2034)
11.2.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by End-use (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by End-use (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by End-use (2021-2034)
11.3.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by End-use (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by End-use (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by End-use (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by End-use (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by End-use (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by End-use (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Hamamatsu Photonics K.K.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Olympus Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. PerkinElmer Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Becton, Dickinson and Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Carl Zeiss AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Andor Technology Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Affymetrix, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bruker Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Newport Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample